PNT was evaluated in in vivo models of mice with CML xenografted with Ba/F3 cells, which were transfected with both wild-type BCR-ABL1 and the BCR-ABL1T315I mutation. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.